Warhound Secures Funding for Genetically Modified Military Canines

Military operations are increasingly incorporating advanced biotechnology, leading to the creation of a new venture focused on canine performance. On October 23, 2026, reports confirmed that Warhound, a startup founded by Oculus co-founder Palmer Luckey, has raised $200 million in capital to genetically engineer dogs for military service.

The company stated that its primary goal is to create animals capable of detecting explosives and protecting troops in the field. Investors in the round include Sequoia Capital. Warhound is partnering with Colossal Biosciences to handle the cloning and gene-editing processes required for the project.

Luckey, who previously founded Oculus and Anduril Industries, established Warhound to bridge the gap between software and biological hardware. The startup aims to use genetic modifications to enhance specific sensory traits in dogs, moving beyond traditional training methods to create a new class of military asset.

The funding announcement comes as the defense sector explores new ways to integrate biological systems with technological infrastructure. Colossal Biosciences, known for its work on de-extinction and gene-editing tools, will provide the technical framework for modifying the animals' DNA. The collaboration suggests a shift toward viewing biological organisms as programmable hardware.

The startup has not yet detailed the specific genes it intends to target or the timeline for the first batch of modified dogs to enter service. However, the involvement of a major venture capital firm and a specialized biotech firm indicates a serious operational plan rather than a conceptual prototype.

The $200 million investment is intended to cover research, development, and initial deployment costs. Warhound plans to use the capital to refine its gene-editing techniques and establish a pipeline for producing enhanced canines. The company will work with military partners to define the specific needs that the genetically modified dogs will address.

The project marks a notable step for Luckey, who has consistently pursued ventures at the intersection of technology and physical systems. The company will rely on the existing infrastructure of Colossal Biosciences to execute the biological work, while Warhound focuses on the military application and strategic direction of the program.